ASHAP--an effective salvage therapy for recurrent and refractory malignant lymphomas.
Hänel M, Kröger N, Hoffknecht MM, Peters SO, Metzner B, Fiedler F, Braumann D, Schubert JC, Illiger HJ, Hänel A, Krüger WH, Zeller W, Weh HJ, Hossfeld DK, Zander AR.
Hänel M, et al. Among authors: weh hj.
Ann Hematol. 2000 Jun;79(6):304-11. doi: 10.1007/s002779900150.
Ann Hematol. 2000.
PMID: 10901609
Clinical Trial.